Stephenson & Company, Inc. Milestone Pharmaceuticals Inc. Transaction History
Stephenson & Company, Inc.
- $174 Billion
- Q3 2025
A detailed history of Stephenson & Company, Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Stephenson & Company, Inc. holds 20,000 shares of MIST stock, worth $38,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$38,000% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
55Shares Held
18.9MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$9.45 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.38 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.76 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.4 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.66 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $57M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...